Top compounds associated with response to GLI3


Feature Type Standardized
Nominal ANOVA
mRNA simvastatin CTRPv2 pan-cancer AAC 0.093 0.03
mRNA BMS-509744 GDSC1000 pan-cancer AAC 0.14 0.03
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.09 0.03
mRNA sitagliptin CTRPv2 pan-cancer AAC 0.18 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.03
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.1 0.03
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.04
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.075 0.04
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.081 0.04
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.04
Download CSV